4//SEC Filing
Boyle Kevin S. Sr. 4
Accession 0001209191-21-065138
CIK 0001107421other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:53 PM ET
Size
6.2 KB
Accession
0001209191-21-065138
Insider Transaction Report
Form 4
Boyle Kevin S. Sr.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2021-11-16$1.40/sh+884$1,238→ 875,884 total - Purchase
Common Stock
2021-11-17$1.40/sh+9,116$12,762→ 885,000 total
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001880600
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:53 PM ET
- Size
- 6.2 KB